Applied Therapeutics Inc
NASDAQ:APLT

Watchlist Manager
Applied Therapeutics Inc Logo
Applied Therapeutics Inc
NASDAQ:APLT
Watchlist
Price: 9.9 USD -3.32% Market Closed
Market Cap: 1.1B USD
Have any thoughts about
Applied Therapeutics Inc?
Write Note

EV/OCF
Enterprise Value to OCF

-13.9
Current
-1.2
Median
6
Industry
Lower than median
Lower than industry value

Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.

EV/OCF
-13.9
=
Enterprise Value
1B USD
/
Operating Cash Flow
-73.2m USD
All Countries
Close
 
US
Applied Therapeutics Inc
NASDAQ:APLT
Average EV/OCF: 23.5
Negative Multiple: -13.9
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -234 904.4
US
Abbvie Inc
NYSE:ABBV
21.4
US
Amgen Inc
NASDAQ:AMGN
28.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -127
US
Gilead Sciences Inc
NASDAQ:GILD
11.3
US
E
Epizyme Inc
F:EPE
Negative Multiple: -479.3
AU
CSL Ltd
ASX:CSL
36.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.6
US
S
Seagen Inc
F:SGT
Negative Multiple: -75
NL
argenx SE
XBRU:ARGX
Negative Multiple: -124.7

EV/OCF Forward Multiples

Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/OCF
N/A
2-Years Forward
EV/OCF
N/A
3-Years Forward
EV/OCF
N/A

See Also

Discover More